Market Mirror Wire

IMARC Group, a leading market research company, has recently releases report titled “ Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028. ” The study provides a detailed analysis of the industry, including the global Biosimilar Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights How big is the Biosimilar market? Report Attributes Details Market Size in 2022 US$ 16.8 Billion Market Forecast in 2028 US$ 77.1 Billion Growth rate (2023 to 2028) CAGR of 25.9% Base Year of the Analysis 2022 Forecast Period 2023-2028 Request for a Free PDF Sample of this Report : https://www.imarcgroup.com/biosimilar-market/requestsample What are Biosimilars? Biosimilars are biopharmaceutical products designed to closely mimic a reference biologic drug. They are manufactured using living organisms and cells with intricate molecular comp...

IMARC Group, a leading market research company, has recently releases report titled “ Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028. ” The study provides a detailed analysis of the industry, including the global Biosimilar Market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights How big is the Biosimilar market? Report Attributes Details Market Size in 2022 US$ 16.8 Billion Market Forecast in 2028 US$ 77.1 Billion Growth rate (2023 to 2028) CAGR of 25.9% Base Year of the Analysis 2022 Forecast Period 2023-2028 Request for a Free PDF Sample of this Report :  https://www.imarcgroup.com/biosimilar-market/requestsample What are Biosimilars services? Biosimilars are biother...

 According to the recent report by IMARC Group, entitled “Biosimilar Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2023-2028 ”, the  global biosimilar market size reached US$ 16.8 Billion in 2022. Looking forward, the market is expected to reach US$ 77.1 Billion by 2028, exhibiting a growth rate (CAGR) of 25.9% during 2023-2028.  Biosimilars, also known as subsequent entry biologics (SEBs) or follow-on biologics, refer to FDA-approved biotherapeutic products which are similar to their reference biologics. Biosimilars can only be manufactured after the patent of the reference product expires. The demand for biosimilars has been increasing in recent years as they help in reducing the overall cost of the treatment for a variety of chronic diseases including cancers, autoimmune diseases, kidney failure, diabetes, CVDs, haematological disorders, infectious diseases, rheumatoid arthritis, growth hormone deficiency, etc. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞...